Driving Innovation in Antibody Discovery and Development Through Novel Partnership Models In this webinar, Dr Robert Williams, Chief Development Scientist, Cancer Research UK, will discuss how partnership between academia and industry can accelerate drug development.
SiLA—Standards to Improve Overall Lab Efficiency This talk covers how SiLA (Standardization in Lab Automation) makes laboratory integration simpler today and in the future.
The Lipidyzer™ Platform: A Revolutionary Tool for Understanding the Role of Lipids in Disease Join us to learn about the key challenges in lipid analysis and how the Lipidyzer platform can help you overcome them.
High Content Biology & Cardiac Regeneration: Proliferation and Multi-lineage Differentiation Screens using Cardiac Progenitor Cells Lauren Drowley, Associate Principal Scientist, AstraZeneca, speaking at Stem Cells in Drug Discovery.
iPS Cells for Muscle Disorders: From Regenerative Medicine to Disease Modelling Francesco Saverio Tedesco, Principal Research Associate, UCL, speaking at Stem Cells in Drug Discovery.
High Content Analysis using Stem Cells for Disease Modelling and Drug Discovery Davide Danovi, Director, Kings College London, speaking at Stem Cells in Drug Discovery.
Developing Predictive Hepatocyte Models from Pluripotent Stem Cells David Hay, Principal Investigator, MRC Centre for Regenerative Medicine, speaking at Stem Cells in Drug Discovery.
Practicalities of Automating Human Interaction with Robotic Cells This webinar will look at the use of industrial robots in work cells where operators need to load and unload products from the robots working area and what safety preclusions and solutions are available.
Human ESC-derived Cardiomyocytes Michael Clements, Scientist, GE Healthcare, speaking at Stem Cells in Drug Discovery.
Disease Modelling and Drug Discovery in Neurological Disorders Zameel Cader, Director and Principal Scientist, IMI StemBANCC, University of Oxford, speaking at Stem Cells in Drug Discovery.